BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

983 related articles for article (PubMed ID: 17979715)

  • 1. The "Epigenetic Code Replication Machinery", ECREM: a promising drugable target of the epigenetic cell memory.
    Bronner C; Chataigneau T; Schini-Kerth VB; Landry Y
    Curr Med Chem; 2007; 14(25):2629-41. PubMed ID: 17979715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecule modulators in epigenetics: implications in gene expression and therapeutics.
    Swaminathan V; Reddy BA; Ruthrotha Selvi B; Sukanya MS; Kundu TK
    Subcell Biochem; 2007; 41():397-428. PubMed ID: 17484138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone modification therapy of cancer.
    Biancotto C; Frigè G; Minucci S
    Adv Genet; 2010; 70():341-86. PubMed ID: 20920755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for compounds that modulate epigenetic regulation of the transcriptome: an overview.
    Eglen RM; Reisine T
    J Biomol Screen; 2011 Dec; 16(10):1137-52. PubMed ID: 22002420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone modification enzymes: novel targets for cancer drugs.
    Kristeleit R; Stimson L; Workman P; Aherne W
    Expert Opin Emerg Drugs; 2004 May; 9(1):135-54. PubMed ID: 15155140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling of epigenetic chromatin modification enzymes and histone marks by cigarette smoke: implications for COPD and lung cancer.
    Sundar IK; Rahman I
    Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1245-L1258. PubMed ID: 27793800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversing aberrant methylation patterns in cancer.
    Poke FS; Qadi A; Holloway AF
    Curr Med Chem; 2010; 17(13):1246-54. PubMed ID: 20166939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histones and histone modifications.
    Peterson CL; Laniel MA
    Curr Biol; 2004 Jul; 14(14):R546-51. PubMed ID: 15268870
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression analysis of the epigenetic methyltransferases and methyl-CpG binding protein families in the normal B-cell and B-cell chronic lymphocytic leukemia (CLL).
    Kn H; Bassal S; Tikellis C; El-Osta A
    Cancer Biol Ther; 2004 Oct; 3(10):989-94. PubMed ID: 15467427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical regulation of epigenetic modifications: opportunities for new cancer therapy.
    Zheng YG; Wu J; Chen Z; Goodman M
    Med Res Rev; 2008 Sep; 28(5):645-87. PubMed ID: 18271058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone-modifying enzymes: encrypting an enigmatic epigenetic code.
    Couture JF; Trievel RC
    Curr Opin Struct Biol; 2006 Dec; 16(6):753-60. PubMed ID: 17070031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA Methylation Targeting: The DNMT/HMT Crosstalk Challenge.
    Castillo-Aguilera O; Depreux P; Halby L; Arimondo PB; Goossens L
    Biomolecules; 2017 Jan; 7(1):. PubMed ID: 28067760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role dietary of bioactive compounds on the regulation of histone acetylases and deacetylases: a review.
    Vahid F; Zand H; Nosrat-Mirshekarlou E; Najafi R; Hekmatdoost A
    Gene; 2015 May; 562(1):8-15. PubMed ID: 25701602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linking epigenetics to lipid metabolism: focus on histone deacetylases.
    Ferrari A; Fiorino E; Giudici M; Gilardi F; Galmozzi A; Mitro N; Cermenati G; Godio C; Caruso D; De Fabiani E; Crestani M
    Mol Membr Biol; 2012 Nov; 29(7):257-66. PubMed ID: 23095054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promises and challenges of anticancer drugs that target the epigenome.
    Verbrugge I; Johnstone RW; Bots M
    Epigenomics; 2011 Oct; 3(5):547-65. PubMed ID: 22126246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Targeted epigenetic therapy of cancer. Achievements and perspectives].
    Valdespino-Gómez VM; Valdespino-Castillo VE
    Cir Cir; 2012; 80(5):470-80. PubMed ID: 23351455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epi-drugs to fight cancer: from chemistry to cancer treatment, the road ahead.
    Mai A; Altucci L
    Int J Biochem Cell Biol; 2009 Jan; 41(1):199-213. PubMed ID: 18790076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of neurogenesis by targeting epigenetic enzymes using small molecules: an overview.
    Swaminathan A; Kumar M; Halder Sinha S; Schneider-Anthony A; Boutillier AL; Kundu TK
    ACS Chem Neurosci; 2014 Dec; 5(12):1164-77. PubMed ID: 25250644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Update of Epigenetic Drugs for the Treatment of Cancers and Brain Diseases: A Comprehensive Review.
    Sahafnejad Z; Ramazi S; Allahverdi A
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic cancer therapy: Proof of concept and remaining challenges.
    Mund C; Lyko F
    Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.